Chemokine analysis highlighted CCR2, CXCR2, CXCR4 and C5aR ligands/chemoattractants as possible targets to decrease the immune myeloid suppressive cells in NMIBC, but also revealed a complex chemokine crosstalk, which deserve particular attention to design novel anti-tumor-treatments. This evidence concerns the gene CCR2 and neoplasm.